Jakap Koo, Director at Apimeds Pharmaceuticals US, Inc., holds 643.88K shares in Apimeds Pharmaceuticals US, Inc. (Ticker: APUS). Most recently, Jakap Koo Bought 28,500 shares of Apimeds Pharmaceuticals US, Inc. on May 14, 2025 for an estimated value of $56.72K.
What is the percentage of profitable transactions made by Jakap Koo?
The percentage of profitable transactions made by Jakap Koo is ―.
What is the average return per transaction made by Jakap Koo?
The average return per transaction made by Jakap Koo is ―.
What stocks does Jakap Koo hold?
Jakap Koo holds: APUS stocks.
What was Jakap Koo’s latest transaction?
Jakap Koo latest transaction was an Informative Buy of $56.72K.
What was Jakap Koo's most profitable transaction?
Jakap Koo’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jakap Koo's role in Apimeds Pharmaceuticals US, Inc.?
Jakap Koo's role in Apimeds Pharmaceuticals US, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.